Sanofi announced a major strategy shift today that will end the pharma’s diabetes and cardiovascular R&D efforts in favor of a reinvigorated focus on growing its immunology and vaccine businesses.
Among the fallout of this new game plan is Onduo, the pharma’s diabetes management joint venture with Verily that the two companies invested $500 million into back in 2016, according to the company’...
Gainesville, Florida-based etectRx has received FDA 510(k) clearance for its ID-Cap System, a prescription ingestible system that sends adherence event logs to an external medical device.
Similar to the system pioneered by etectRx’s high-profile competitor, Proteus Digital Health, the ID-Cap’s core is a standard capsule containing a sensor that transmits a message once it comes into contact with...
Proteus Digital Health, maker of an ingestible sensor system for treatment adherence monitoring, was forced to furlough many of its employees last month after a $100 million funding round didn’t close as expected, according to a weekend report from CNBC.
These employees were brought back after about two weeks after Proteus was able to secure $5 million in emergency funding, according to the...
The FDA and National Institutes of Health are tapping the clinical community and a newly launched mobile platform in its search for novel infectious disease interventions.
Called CURE ID, the online data repository will allow clinicians to report instances in which existing FDA-approved drugs are used to successfully treat infections.
In particular, the tool captures clinical outcomes in cases...
AdhereTech’s smart pill bottle platform improved adherence and patient satisfaction among a small sample of multiple myeloma patients, according to a paper in the November issue of the Journal of Managed Care & Specialty Pharmacy.
This data has been roughly four years in the making, and stands the company’s first-ever peer-reviewed publication of adherence efficacy, AdhereTech CEO and...
(L to R) Andrew Hopper, Carson Pickens, Gilad Jacobs, Stacie Ruth, Grace Cordavano, and Kelly McKee discuss Patient Co-Creation last month at the Connected Health Conference in Boston. Photo by Jonah Comstock.
Healthcare stakeholders — from providers to payers to pharma and medical device companies — are more and more starting to include patients in the design process for new innovations and initiatives. But while that co-design is a good first step, it’s not enough, experts at the Connected Health Conference in Boston last month argued.
“Every health innovator wants to maximize their market success,”...
Welldoc is tapping Astellas Pharma to assist Japanese and Asian commercialization efforts for the former’s digital therapeutic for patients with diabetes, the companies announced yesterday.
To kick off the deal, Astellas is making an upfront $15 million payment to Welldoc, which will allow the pharma to jointly develop and commercialize the BlueStar product in the region. The two will also be...
Yesterday Propeller Health, maker of digital management tools for patients with respiratory conditions, announced a new deal with CVS, Walmart, Kroger, and Rite Aid, allowing its members to tap into the retail giants’ pharmacy services through the Propeller app.
Propeller is best known for its sensor-enabled inhalers, which can give patients and providers insights about use, symptom triggers and...
This morning Deloitte launched ConvergeHEALTH Connect, a new suite of four new healthcare products targeting a range of concentrations from public health care to personalized care, all of which runs on the Salesforce Health Cloud.
The full list includes tools for patient engagement, public health programs, providers and payers.
The first tool specifically aims to help life science companies...
Photo courtesy of Janssen Pharmaceutical Companies. From left to right: panel moderator Patrick Wayte, Dr. C. Michael Gibson and Dr. Paul Stoffels.
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia.
These comments were accompanied by the official kickoff of CHIEF-HF,...
